← Back to Search

Omega-3 Fatty Acid

Fish Oil for Total Hip Replacement

N/A

Recruiting

Led By Jeffrey D Stimac, MD

Research Sponsored by Jeffrey L Stimac MD

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up post-operative day 5

Awards & highlights

Study Summary

This trial is testing whether continuing to take fish oil supplements before and after surgery leads to more blood loss and less pain afterwards.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ post-operative day 5

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~post-operative day 5

This trial's timeline: 3 weeks for screening, Varies for treatment, and post-operative day 5 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Total perioperative blood loss

Secondary outcome measures

Post-operative day 1 Hematocrit

Post-operative day 1 Hemoglobin

Other outcome measures

Post-operative pain scores

Side effects data

From 2007 Phase 1 & 2 trial • 39 Patients • NCT00090402

15%

Dizziness

15%

cold

Falls

Heart Failure

100%

80%

60%

40%

20%

Study treatment Arm

Fish Oil

Fish Oil Plus Lipoic Acid

Placebo

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Fish OilExperimental Treatment1 Intervention

Fish-Oil naïve subjects will be started on fish oil 4 weeks prior to surgery and continued until the 6 week follow up. Subjects already taking fish oil will be switched to the study fish-oil formulation of two capsules twice daily (3000 mg of EPA and DHA).

Group II: ControlActive Control1 Intervention

No fish oil supplementation

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Fish Oil

2006

Completed Phase 4

~1370

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Jeffrey L Stimac MDLead Sponsor

Jeffrey D Stimac, MDPrincipal InvestigatorNorton Healthcare

Media Library

Fish Oil (Omega-3 Fatty Acid) Clinical Trial Eligibility Overview. Trial Name: NCT04360239 — N/A

Total Hip Replacement Research Study Groups: Fish Oil, Control

Total Hip Replacement Clinical Trial 2023: Fish Oil Highlights & Side Effects. Trial Name: NCT04360239 — N/A

Fish Oil (Omega-3 Fatty Acid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04360239 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts underway for this research project?

"According to the clinicaltrial.gov listing, this medical research is presently enrolling participants and was originally posted on June 1st 2020. The entry was last modified on June 3rd 2022."

Answered by AI

Do I meet the eligibility criteria for participating in this clinical investigation?

"Qualifying criteria for this clinical trial stipulates that participants must have st13 protein, human and range between 18-99 years of age. A total of 120 volunteers are being sought out to participate."

Answered by AI

What is the uppermost limit of participants in this research endeavor?

"Affirmative. The clinicaltrial.gov website reflects that this medical experiment is currently in search of volunteers; it was first published on June 1st 2020 and subsequently updated on June 3rd 2022. A total number of 120 participants are required to be recruited from one trial site."

Answered by AI